Study of the Effect of Bacteriocin-producing Bacillus subtilis Strains on Beta-lactamase-producing Pathogenic Bacteria
Journal of Clinical Research in Paramedical Sciences · 2022
DOI: 10.5812/jcrps-130208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Research in Paramedical Sciences, 2022. Verfasst von Ciamak Ghazaei. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The emergence of antimicrobial resistance results in morbidities and mortalities associated with many bacterial infections and is a major concerning issue in front of the healthcare system. As a part of a competitive adaptive strategy for its growth, gram-positive bacteria like Bacillus subtilis produce antimicrobial peptides; bacteriocins. These peptides protect other bacterial species.
Objectives
To counter antimicrobial resistance, bacteriocins can be considered a potential drug option against drug-resistant microorganisms.
Methods
After isolation and characterisation of B. subtilis from the 5 collected soil samples, the bacteriocin was extracted from these bacteria by using the ‘solvent extraction method’, characterised, and then purified to evaluate its antimicrobial activity against pathogenic bacteria like; Streptococcus pyogenes, Salmonella typhi, Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii by using ‘Kirby-Bauer disc diffusion’, method. The bacteriocin stability was also investigated, at different temperatures, pH and incubation times.
Results
The bacteriocin of B. subtilis showed great antimicrobial activity against S. pyogenes, followed by S. typhi and P. aeruginosa. However, the lowest antimicrobial activity was against A. baumannii. With the increase in the incubation time and temperature, the antimicrobial activity of bacteriocin was decreased, indicating the protein nature of bacteriocin. Compared to the standard antibiotics, the bacteriocin isolated from B. subtilis demonstrated a significant inhibitory effect against the tested pathogens.
Conclusions
From this study, it can be concluded that bacteriocin can become a potential alternative to standard available medicines. They can be used against antimicrobial-resistant pathogenic bacteria because of their significant inhibitory activity against the tested pathogens compared to the standard antibiotics.
Zitieren
APA
Ghazaei, C. (2022). Study of the Effect of Bacteriocin-producing Bacillus subtilis Strains on Beta-lactamase-producing Pathogenic Bacteria. Journal of Clinical Research in Paramedical Sciences. https://doi.org/10.5812/jcrps-130208
Vancouver
Ghazaei C. Study of the Effect of Bacteriocin-producing Bacillus subtilis Strains on Beta-lactamase-producing Pathogenic Bacteria. Journal of Clinical Research in Paramedical Sciences. 2022. doi:10.5812/jcrps-130208
BibTeX
@article{Ghazaei2022,
author = {Ghazaei, Ciamak},
title = {Study of the Effect of Bacteriocin-producing Bacillus subtilis Strains on Beta-lactamase-producing Pathogenic Bacteria},
journal = {Journal of Clinical Research in Paramedical Sciences},
year = {2022},
doi = {10.5812/jcrps-130208}
}
EUVIMED